Caveolin expression in adult renal tumors

Urologic Oncology: Seminars and Original Investigations

Volumn 21, Issue 3, 2003, Pages 191-196

  Carrion, Rafael ^a   Morgan, Beale E ^b   Tannenbaum, Myron ^a   Salup, Raoul ^a,b   Morgan, Michael B ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Caveolin; Malignant renal tumors; Oncocytoma; Renal cell carcinoma

Indexed keywords

CAVEOLIN; CELL MEMBRANE PROTEIN;

ARTICLE; CANCER INCIDENCE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUMOR; LABELING INDEX; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0037663885     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1078-1439(02)00235-1     Document Type: Article

References (20)

1. deKernion JB, Belldegrun A. Renal tumors. In: Walsh PC, Retik AB, Wein AB, Vaughan ED Jr., editors. Campbell's Urology. 7th Edition. Philadelphia: W. B. Sanders Company, 1998. pp. 2284.
2. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics 1998. CA Cancer J Clin 1998;48:6-29.
3. Chang A, Harawi SJ. Oncocytes, Oncocytosis, and Oncocytic tumors. Pathol Annu 1992;27:263-304.
4. Eble JN, Hull MT. Morphologic Features of Renal Oncocytoma. A light and electron microscopic study. Hum Pathol 1984;15:1054-1061.
5. Liu J, Razani B, Tang S, et al. Angiogenesis activators and inhibitors differently regulate caveolin expression and caveola formation in vascular endothelial cells. J Biol Chem 1999;274:15781.
6. Okamoto T, Schlegel A, Scherer P, et al. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes: and the plasma membrane. J Biol Chem 1999;274:5419.
7. Breton S, Lisanti MP, Tyszkowski R, et al. Basolateral distribution of caveolin-1 in the kidney: Absence from H+-ATPase-coated endocytic vesicles in intercalated cells. The J of Hist & Cytochem 1998;46:205-14.
8. Engelman JA, Zhang XL, Listani MP. Genes encoding human caveolin-1 and -2 are co-localized to the D7s522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Letters 1998;436:403-410.
9. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Kidney cancer incidence trends in the United States. JAMA 1999;281:1628-1631.
10. Zbar B, Lerman M. Inherited carcinomas of the kidney. Adv Cancer Res 1998;75:163-201.
11. Lieber MM, Tomera KM, Farrow GM. Renal Oncocytoma. J Urol 1981;125:481-485.
12. Barnes CA, Beckman EN. Renal oncocytoma and its congeners. Am J Clin Pathol 1983;79:312-318.
13. Merino MJ, LiVolsi VA. Oncocytomas of the kidney. Cancer 1982; 50:1852-1856.
14. Davis CJ Jr, Sesterhenn IA, Mostofi FK, Ho CK. Renal oncocytoma. Clinicopathological study of 166 patients. J Urogen Pathol 1991;1:41-52.
15. Weiss MD, Gelb AB, Medeiros J. Adult Renal Epithelial Neoplasms. Am J Clin Pathol 1995;103:624.
16. Fujimoto T. Calcium pump of the plasma membrane is localized in caveolae. J Cell Biol 1993;120:1147-57.
17. Herblin W, Brem S, Fan T. Recent advances, in angiogenesis inhibitors. Exp Opin Ther Patients 1994;4:641.
18. Koleske A, Baltimore D, Lisanti M. Loss of caveolin expression following cell transformation by activation of Ha-ras oncogene. Proc Natl Acad Sci USA 1995;92:1381.
19. Engelman J, Wykoff C, Yasuhara S, Song K, et al. Induction of caveolin in Ha-ras transformed cells abrogates anchorage-independent growth. J Biol Chem 1997;272:16374.
20. Hayashi K, Matsuda S, Machida K, Yamamoto T, et al. Invasion activation caveolin-1 mutation in human scirrhous breast cancers. Can Res 2001;61:2361-64.